PD-L1 Expression in Sarcomas: An Immunohistochemical Study

被引：0
|
作者：
Cunningham, C. [1 ]
Schnabel, J. [1 ]
Esebua, M. [1 ]
Layfield, L. [1 ]
机构：
[1] Univ Missouri, Pathol & Anat Sci, Columbia, MO USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2020年 / 154卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S48 / S49
页数：2
相关论文
共 50 条
  • [21] PD-L1 expression in soft tissue sarcomas and its prognostic implication.
    Kelany, Mohamed Reda
    Barth, Thomas
    Salem, Dina
    Mosaad, Marwa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Expression of PD1 and Its Ligand PD-L1 in Thymic Epithelial Neoplasms: An Immunohistochemical Study of 100 Cases
    Weissferdi, Annikka
    Kalhor, Neda
    Fujimoto, Junya
    Canales, Jaime Rodriguez
    Mino, Barbara
    Nunomura, Sayuri
    Cuentas, Edwin Parra
    Wistuba, Ignacio
    Moran, Cesar
    MODERN PATHOLOGY, 2015, 28 : 492A - 492A
  • [23] Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study
    L. R. Greeshma
    Anna P. Joseph
    T. T. Sivakumar
    Varun Raghavan Pillai
    Gopikrishnan Vijayakumar
    Scientific Reports, 13 (1)
  • [24] Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study
    Greeshma, L. R.
    Joseph, Anna P.
    Sivakumar, T. T.
    Pillai, Varun Raghavan
    Vijayakumar, Gopikrishnan
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [25] PD-L1 Expression in Metaplastic Breast Carcinoma (MBC) Using PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical (IHC) Assays
    Grabenstetter, Anne
    Jungbluth, Achim
    Frosina, Denise
    Hoda, Raza
    Weigelt, Britta
    Reis-Filho, Jorge
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark
    Brogi, Edi
    Wen, Hannah
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 159 - 160
  • [26] Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
    Kiraly, Zsofia
    Szepesi, Agota
    Sebestyen, Anna
    Kuroli, Eniko
    Rencz, Fanni
    Toth, Bela
    Bokor, Laura
    Szakonyi, Jozsef
    Medvecz, Marta
    Hidvegi, Bernadett
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [27] PD-L1 Expression in Metaplastic Breast Carcinoma (MBC) Using PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical (IHC) Assays
    Grabenstetter, Anne
    Jungbluth, Achim
    Frosina, Denise
    Hoda, Raza
    Weigelt, Britta
    Reis-Filho, Jorge
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark
    Brogi, Edi
    Wen, Hannah
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 159 - 160
  • [28] Immunohistochemical analysis of PD-L1 expression in malignant melanomas and melanocytic nevi
    Zidlik, V.
    Ziak, D.
    Brychtova, S.
    Uvirova, M.
    Sustikova, J.
    Nieslanik, J.
    Ondrussek, R.
    Hurnik, P.
    Faistova, H.
    Dvorackova, J.
    VIRCHOWS ARCHIV, 2017, 471 : S169 - S169
  • [29] PD-L1 Expression in Malignant Mesothelioma: An Immunohistochemical Analysis of 33 Cases
    Cowan, M. L.
    Forde, P. M.
    Taube, J. M.
    Brahmer, J.
    Illei, P. B.
    LABORATORY INVESTIGATION, 2014, 94 : 476A - 476A
  • [30] Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression. in epithelioid peritoneal malignant mesothelioma: A RENAPE study
    Valmary-Degano, S.
    Colpart, P.
    Villeneuve, L.
    Monnien, F.
    M'Hamdi, L.
    Averous, G. Lang
    Capovilla, M.
    Bibeau, F.
    Laverriere, M. -H.
    Verriele-Beurrier, V.
    Ben Rejeb, H.
    Dartigues, P.
    Hommell-Fontaine, J.
    Gilly, F. -N.
    Isaac, S.
    Mery, E.
    EJSO, 2017, 43 (10): : 1915 - 1923
12345